EnvoyAI today announced a new integration with Insignia Medical Systems’ InSight PACS to provide AI-enhanced imaging workflows to customers. For initial launch in the UK, this integration provides best-of-breed, curated AI content available on the EnvoyAI platform within the PACS environment at multiple integration points. These include AI results viewing directly within the PACS viewer, as well as within the already established Insignia integration with TeraRecon. EnvoyAI is the spinout formed by a 2017 TeraRecon acquisition of McCoy Medical Technologies. TeraRecon’s longstanding partnership with Insignia is further strengthened with the synergies between EnvoyAI’s platform and TeraRecon’s latest advanced visualisation offerings.
The integrations with EnvoyAI and TeraRecon allow hospitals to customize their AI portfolio based on algorithms they can test and consume from within their Insignia PACS, including the utilisation of each hospital’s own internally developed algorithms. Jon Hall, Chief Technology Officer, Insignia Medical Systems shared, “Integrating to the EnvoyAI platform allows Insignia to more quickly and broadly execute on our goal of providing the most advanced functionality on the market to our end users. The integration provides instant access to premium AI directly as part of a cohesive end-user experience - expanding how we add value for our customers within a single, powerful interface.”
The EnvoyAI platform readies the Insignia InSight PACS for the launch of any AI application – starting with the AI content already available on the EnvoyAI Exchange. With recent growth, the EnvoyAI Exchange now offers a total of 53 products from 22 partners, of which 10 have already achieved US FDA-clearance. The partnership creates added potential for future workflow integrations to TeraRecon’s iNtuition advanced visualisation solution
already promoted by Insignia, as well as TeraRecon’s new NorthStar AI-results viewer for advanced physician interactions.
Maria Proud-Levitas, Regional Sales Manager for TeraRecon (UK) said, “Working closely with Insignia for over 5 years has created a very clean and powerful offering for our customers. Building on that trust, we now look forward to delivering tools that take UK healthcare boldly into the future.”
Steven Rothenberg, MD and Chief Medical Officer of EnvoyAI stated, “The Insignia PACS integration makes the widespread use of AI an immediate reality for clinicians across the UK; allowing for the most rigorous data security protocols with on-premise installations. EnvoyAI is keen on bringing AI to clinicians in ready-to-use, powerful ways.”
Richard Dormer, Managing Director of Insignia, said, “We are excited to be building on our already fantastic relationship with TeraRecon to include the advanced technology available through EnvoyAI, which will ultimately help our customers and improve outcomes for patients.”
Learn more about TeraRecon